subcutaneous immunotherapy
The build-up phase outcome of subcutaneous immunotherapy for pediatric allergic asthma: A retrospective cohort study from Surabaya, Indonesia
... Aim: This study aims to assess the build-up phase outcomes of subcutaneous immunotherapy (SCIT) for pediatric allergic asthma. Methods: The retrospective cohort study comprised 65 children with allergic ...
6
Subcutaneous Immunotherapy in Patients with Fagales Pollen Induced Oral Allergy Syndrome
... Oral allergy syndrome (OAS) is the most common food allergy-related condition in adults. This study aimed to investigate whether subcutaneous immunotherapy (SCIT) with Fagales pollen-containing extracts can ...
6
Original Article A comparative study of sublingual and subcutaneous immunotherapy in mite-sensitive asthmatic children: a single center experience of 90 Chinese patients
... Abstract: Objective: Asthma is a heterogeneous disease with the geographic and ethnic diversity. Present study aimed to compare between sublingual (SLIT) and subcutaneous immunotherapy (SCIT) in Chinese ...
8
Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients
... or subcutaneous immunotherapy (non- SIT); and 33 participants (14 women and 19 men, with an average of 31 ± 11 years of age) with respiratory allergy, rhinitis and allergic controlled asthma to Dpt, ...
13
Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus
... specific immunotherapy, and that displayed the same clinical profile and the exclusion criteria as the SCIT group (age: 26 ± 7 years; sex: 3 males/7 females) was studied (Table ...
10
<p>Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis</p>
... c immunotherapy (AIT) is the only treatment available that can prevent the natural progression of allergic rhinitis ...1 Subcutaneous immu- notherapy (SCIT) is one of the main methods of implementing AIT, ...
10
Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE Blocking Factors for Three Mite Subcutaneous Immunotherapy Products
... Purpose: Specific immunoglobulin G4 (sIgG4) and immunoglobulin E (IgE)-blocking factors produced by subcutaneous immuno- therapy (SCIT) play a critical role in the induction of allergen tolerance. However, ...
8
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy
... Together with the significant reduction in allergic symptoms, several studies on SIT have documented a sig- nificant reduction in the need for symptomatic drugs on short term as well as during long-term treatment [51-54] ...
11
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
... The mean lowest concentration that induced a posi- tive (grade II) conjunctival reaction to HDM allergen solution after 6 doses (visit 8) and at the end of study (i.e., two weeks after receiving the last maintenance ...
8
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies
... of immunotherapy for food allergy, most attention has so far been given to peanut egg and milk, as these foods are important causes of severe food allergy, mainly in ...ongoing. Subcutaneous ...
9
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
... specific immunotherapy (AIT) has provided a safe and effective treatment method, particularly for allergic rhi- ...controlled immunotherapy trials exhibiting a high degree of safety and efficacy have been ...
9
Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis
... The analyzed data were extracted from the published articles. The means and standard deviations of cSMS, RCSS and overall RQLQ score in active (immunotherapy with DPAEs) and placebo groups were extracted for each ...
15
Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
... received subcutaneous immunother- apy between January 2007 and August ...for immunotherapy were house dust mites (HDMs) as well as tree, grass, or weed pollens, which were de- termined by physicians through ...
8
Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center
... health care system is different than Germany’s, which may generally prevent the comparability of study results from these countries. In the Netherlands, often the patient’s first contact with immunotherapy is ...
8
Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
... antibodies have been shown to be prominent immuno- globulins in the sustained regulation of food allergies in human immunotherapy trials [6, 40]. In a murine model, mast cell degranulation and IgE-mediated ...
12
Peanut immunotherapy
... peanut immunotherapy was attempted in a small study in 1992, where an initial rush injection schedule was administered, followed by once-weekly maintenance injections for 4 ...that subcutaneous ...
6
Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
... Allergen-specific subcutaneous immunotherapy is an effective treatment for certain allergic ...the subcutaneous space in the mid-posterolateral upper ...
5
Allergen-specific immunotherapy
... Sublingual immunotherapy is a novel way of desensitizing patients and involves placing a tablet of allergen extract under the tongue until it is ...tablet immunotherapy products are available in Canada: ...
10
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
... AIT, subcutaneous immunotherapy (SCIT), is effective and safe in respiratory allergies and insect venom hypersensitivities [5–7] and has been rec- ognized as the gold standard immunotherapy method ...
13
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
... Other organizations, both U.S.-based and international, have developed guidelines concerning the clinical manage- ment of prostate cancer. Sipuleucel-T is currently the only immunotherapeutic agent approved by the U.S. ...
12